For many years, aspirin has traditionally been used to treat pain and inflammation, as well as to reduce temperature. However, scientists now claim that daily intake of aspirin can help prevent the development of cancerous tumors.

It has already been shown that aspirin reduces the risk of developing certain types of cancer. Now scientists from Veterans Affairs (Texas, USA) have understood, how aspirin works.

It turns out that aspirin interacts with platelets, the role of which is to prevent bleeding due to the formation of thrombi. And it is this interaction between aspirin and platelets that does not allow tumors to grow. Normally, platelets help in the formation of new blood vessels after the thrombus is formed. But the same process helps tumors to survive and expand. Aspirin disrupts the process of normal blood clotting by "turning off" the key enzyme COX-1 and, thereby, blocking the interaction of platelets and cancer cells.

True, it is worth noting that in the study, scientists used a special mixture of aspirin and phosphatidylcholine (the type of lipids contained in soy lecithin). The second component reduces the harm to the gastrointestinal tract caused by aspirin. The mixture was named "Aspirin-PC / PL2200".

Scientists hope that this mixture will be included in the scope of anticancer therapy.

It should also be noted that recently a study of scientists from British universities Newcastle and Leeds showed that daily intake of aspirin can reduce the risk of developing bowel cancer in people who are overweight and obese. And scientists from the University of Cardiff reported that the benefits of daily intake of aspirin outweigh the shortcomings, such as, for example, possible gastric bleeding.

aspekty. net.